Advertisement
About Regado Biosciences
Regado Biosciences is pioneering a new therapeutic field with thediscovery and development of drug:antidote systems. Regado's drug:antidotesystems are designed to give physicians the ability to fine-tune thetherapeutic effect desired for each patient and in each setting. A spin-outof the Department of Surgery at Duke University Medical Center, Regado wascreated to answer the therapeutic needs identified by its scientific founders.
Advertisement
The Company's proprietary platform technology enables the discovery ofoligonucleotide-based drug-antidote pairs to any target protein. Regadoinitially is focusing its discovery and development efforts on the acute careinjectable antithrombotics, a multi-billion dollar market in need oftherapeutics with improved safety profiles. Potential future indications forRegado's technology include acute coronary syndromes and other coronaryrevascularization procedures that would benefit from the availability of anantidote-reversible agent.
SOURCE Regado Biosciences
